Document is current
Any future updates will be listed below
-
Authors
Riley, Elise D.
Chur, Elizabeth
Gandhi, Monica
Fuchs, Jonathan D.
Sauceda, John A.
Sterling, Lauren A.
Johnson, Mallory O.
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (K24 DA039780, K24 DA039780)
National Institute of Allergy and Infectious Diseases (P30 AI027763, P30 AI027763, P30 AI027763, P30 AI027763, P30 AI027763)
National Institute of Mental Health (P30 MH062246)
- License Information
-
More Information
Article History
Received: 19 March 2024
Accepted: 1 August 2024
First Online: 28 August 2024
Declarations
:
: This study is based on program evaluation materials and did not involve human subjects as defined by the federal regulations summarized in 45 CFR 46.102(e). The Institutional Reivew Board at the University of California San Francisco therefore determined that it did not require IRB oversight (University of California San Francisco IRB# ; IRB Determination Reference #391553).
: This study did not include human subjects as defined by the federal regulations summarized in 45 CFR 46.102(e); it did not include identifiable information for any individual.
: The authors declare no competing interests.
